Professor Norman Saunders, an expert on developmental neuroscience, has spoken out on the science behind the controversy over paracetamol use in pregnancy.
In an announcement made by the Minister for Health, the Hon. Sussan Ley, and the NHMRC, the Melbourne Healthcare Partners Advanced Health Research and Translation Centre was recognised as only one of four Advanced Health and Research Translation Centres in Australia.
Included in the Melbourne Healthcare Partners were some of Australia’s best medical and health care institutions – Austin Health, Mercy Health, Melbourne Health, Northern Health, Peter MacCallum Cancer Centre, Royal Children’s Hospital, Royal Victorian Eye and Ear Hospital, Royal Women’s Hospital, St Vincent’s Hospital Melbourne, and Western Health – together with supporting partners the Bionics Institute, Centre for Eye Research Australia, CSL Limited, The Florey Institute of Neuroscience and Mental Health, Murdoch Childrens Research Institute, St Vincent’s Institute for Medical Research, the University of Melbourne and the Walter and Eliza Hall Institute of Medical Research.
Royal Melbourne’s Chief Executive, Dr Gareth Goodier, said the establishment of the Advanced Health Research and Translational Centre further supported Melbourne as a centre of health and medical research in Australia.
“This recognition reinforces the leading role the partners in Melbourne’s Biomedical Precinct, based in Parkville, have in the investment and development of medical research to its translation to patient care,” Dr Goodier said.
“We are enormously proud of the research-led care we provide at The Royal Melbourne Hospital and to be considered at the top international level, further strengthens our drive to continue working with some of the best medical research and healthcare organisations in Australia.”
The international review panel of Professor Sir Robert Lechler (Kings College London), Professor Dermott Kelleher (Imperial College London), Prof. Tom Walley (Liverpool University), and Professor Martin Schechter (University of British Columbia), considered the Melbourne Healthcare Partners was at the top international level.
The panel noted leadership in four main research themes – cancer, neurosciences, child health and immunology and infectious diseases.
Professor Glyn Davis, Vice Chancellor of the University of Melbourne, said this recognition was a great example of the high benchmark Melbourne’s healthcare and research institutions set themselves in translating medical research advances into clinical practice.
“This initiative is an acknowledgement of the importance of embedding biomedical researchers in clinical settings to speed the translation of research into clinical outcomes for patients, an approach which can produce globally transformative interventions such as the invention of the Cochlear Implant by Graeme Clark and his team. The ultimate goal of the Centre is to improve the health of patients and reduce the time patients spend in hospital care.”
The Melbourne Healthcare Partners is now part of a strong set of Advanced Health Research and Translation Centres around Australia, which has the potential to provide a more powerful base for clinical trials as well as provide much greater efficiency in the use of resources – clinical, community, research and avoiding duplication.
The Austin’s Chief Executive, Dr Brendan Murphy said the establishment of the Advanced Health Research and Translation Centre formalises the collaboration and teamwork already occurring between the Melbourne Healthcare Partners.
“It’s a great honour to be part of a collaborative that has been recognised as one of the world’s best in medical research and health,” Dr Murphy said.
“The Melbourne Healthcare Partners Advanced Health Research and Translation Centre showcases the best of what Australia has to offer in healthcare and medical research.
“And it is through great partnerships like this that we are able to accelerate research findings into health and ways of bringing healthcare problems to the researchers.”